Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Elevated circulating aspartate aminotransferase concentration, Increased serum bile acid concentration, and Elevated circulating alanine aminotransferase concentration. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 3 | Elevated circulating aspartate aminotransferase concentration, Increased serum bile acid concentration, Elevated circulating alanine aminotransferase concentration |
SEMA7A function has not been fully characterized.
Cholestasis, progressive familial intrahepatic, 11 is associated with mutations in the SEMA7A gene on chromosome 15.
Genetic testing for SEMA7A is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features.
No clinical trials have been registered for cholestasis, progressive familial intrahepatic, 11.
27 publications have been identified in PubMed for cholestasis, progressive familial intrahepatic, 11. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (22%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 33% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:42 PM UTC
Online Mendelian Inheritance in Man
Digestive system | 1 | Enlarged liver (hepatomegaly) |
Skin | 1 | Pruritus |
Laboratory research
6 |
22% |
Research summaries | 4 | 15% |
Clinical study results | 3 | 11% |
Disease patterns and progression | 2 | 7% |
New treatment approaches | 2 | 7% |
Other research | 1 | 4% |
Nomden M (2026). [PMID: 40644308](https://pubmed.ncbi.nlm.nih.gov/40644308/). *Hepatology*. [Clinical Trial Publication]
Gadour E (2026). [PMID: 41566726](https://pubmed.ncbi.nlm.nih.gov/41566726/). *Adv Clin Exp Med*. [Review / Meta-Analysis]
de Vries HD (2026). [PMID: 41954415](https://pubmed.ncbi.nlm.nih.gov/41954415/). *Liver Int*. [Basic Science / Preclinical]
Sciveres M (2026). [PMID: 41718432](https://pubmed.ncbi.nlm.nih.gov/41718432/). *Pediatr Rep*. [Review / Meta-Analysis]
Daniel D (2026). [PMID: 41724715](https://pubmed.ncbi.nlm.nih.gov/41724715/). *J Clin Apher*. [Case Report / Case Series]
Bell EL (2025). [PMID: 40513781](https://pubmed.ncbi.nlm.nih.gov/40513781/). *J Lipid Res*. [Basic Science / Preclinical]
Song JQ (2025). [PMID: 40061976](https://pubmed.ncbi.nlm.nih.gov/40061976/). *World J Gastrointest Surg*. [Case Report / Case Series]
Vitale G (2025). [PMID: 39984942](https://pubmed.ncbi.nlm.nih.gov/39984942/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Takaki Y (2025). [PMID: 40679108](https://pubmed.ncbi.nlm.nih.gov/40679108/). *Hepatol Res*. [Case Report / Case Series]
De Vos K (2025). [PMID: 40016501](https://pubmed.ncbi.nlm.nih.gov/40016501/). *AAPS J*. [Basic Science / Preclinical]